Skip to main content

Immunotherapy — State of the Art

Buy Article:

$39.50 plus tax (Refund Policy)


Immunotherapy for hay fever due to ragweed, grass, birch, and mountain cedar pollens and for asthma due to ragweed, grass, house dust mite, and cat dander allergens relieves symptoms in controlled studies. Clinical improvement is specific for the allergen employed, depends on the dose administered, and may relapse six months to a year after injections are stopped. Immunological changes include a rise in IgG antibodies, an early rise and later decline in IgE antibodies, sometimes a rise in secretional antibodies, reduced basophile reactivity and sensitivity, and reduced lymphocyte responsiveness to allergens.

Document Type: Research Article


Publication date: 1985-06-01

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more